Abstract
BackgroundTreatment options for patients with ankylosing spondylitis (AS) are limited to non-steroidal anti-inflammatory drugs (NSAIDs) and to tumour necrosis factor (TNF) α blockers. Treatment of the patients with contraindications/intolerance/absence of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have